Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Bi-allelic Dicer1 mutations in the gynecologic tract of mice drive lineage-specific development of DICER1 syndrome-associated cancer

Cancer Res CAN-22-3620.

https://doi.org/10.1158/0008-5472.CAN-22-3620

Published: 26 July 2023

View article titled, Bi-allelic Dicer1 mutations in the gynecologic tract of mice drive lineage-specific development of DICER1 syndrome-associated cancer

Includes: Supplementary data

Journal Articles

Abstract 23: Development of a biallelicDicer1mutant mouse strain for studying the pathogenesis of DICER1 syndrome-associated cancer

Yemin Wang, Shary Chen, Janine Senz, Maxwell Douglas, Shelby Thornton, Yana Moscovitz, C. Blake Gilks, David Huntsman, Gregg Morin

Cancer Res (2023) 83 (7_Supplement): 23.

https://doi.org/10.1158/1538-7445.AM2023-23

Published: 04 April 2023

View article titled, Abstract 23: Development of a biallelic<em>Dicer1</em>mutant mouse strain for studying the pathogenesis of DICER1 syndrome-associated cancer

Journal Articles

Abstract 3671: Targeting SLC2A1 and SLC38A2-mediated metabolic shift in SMARCA4/A2-dual deficient cancer

Xianbing Zhu, Zheng Fu, Shary Chen, Dionzie Ong, Giulio Aceto, Rebecca Ho, Jutta Steinberger, Eunice Li, David Huntsman, William Foulkes, Sidong Huang, Yemin Wang

Cancer Res (2023) 83 (7_Supplement): 3671.

https://doi.org/10.1158/1538-7445.AM2023-3671

Published: 04 April 2023

View article titled, Abstract 3671: Targeting SLC2A1 and SLC38A2-mediated metabolic shift in SMARCA4/A2-dual deficient cancer

Journal Articles

Abstract 1459: Selective killing of SMARCA4-deficient gynecologic cancers by mitochondria oxidative phosphorylation inhibitors

Yemin Wang, Dionzie Ong, Shary Yuting Chen, Eunice Li, Krystal Orlando, Elizabeth Raupach, Jennifer Ji, Bernard Weissman, Patrick Pirrotte, David Humtsman

Cancer Res (2020) 80 (16_Supplement): 1459.

https://doi.org/10.1158/1538-7445.AM2020-1459

Published: 15 August 2020

View article titled, Abstract 1459: Selective killing of SMARCA4-deficient gynecologic cancers by mitochondria oxidative phosphorylation inhibitors

Journal Articles

Abstract LB-038: Novel functional insights revealed by distinct protein-protein interactions of the residual SWI/SNF complex in SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type

Cancer Res (2020) 80 (16_Supplement): LB-038.

https://doi.org/10.1158/1538-7445.AM2020-LB-038

Published: 15 August 2020

View article titled, Abstract LB-038: Novel functional insights revealed by distinct protein-protein interactions of the residual SWI/SNF complex in SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type

Journal Articles

Abstract 3673: Targeting the epigenome of small cell hypercalcemic carcinoma of the ovary, hypercalcemic type (SCCOHT)

Yemin Wang, Shary Yu-ting Chen, Shane Colborne, Krystal Orlando, Jessica Lang, Anthony Karnezis, William Hendricks, Gregg Morin, Bernard Weissman, Jeffrey Trent, David Huntsman

Cancer Res (2018) 78 (13_Supplement): 3673.

https://doi.org/10.1158/1538-7445.AM2018-3673

Published: 01 July 2018

View article titled, Abstract 3673: Targeting the epigenome of small cell hypercalcemic carcinoma of the ovary, hypercalcemic type (SCCOHT)

Journal Articles

Abstract 4318: Identifying drivers of SMARCA4/BRG1-deficient SCCOHT tumorigenesis by integrative multi-omic analysis

Krystal A. Orlando, Jesse R. Raab, Jessica D. Lang, William P. Hendricks, Yemin Wang, David G. Huntsman, Jeffrey M. Trent, Joel S. Parker, Bernard E. Weissman

Cancer Res (2018) 78 (13_Supplement): 4318.

https://doi.org/10.1158/1538-7445.AM2018-4318

Published: 01 July 2018

View article titled, Abstract 4318: Identifying drivers of SMARCA4/BRG1-deficient SCCOHT tumorigenesis by integrative multi-omic analysis

Journal Articles

Abstract 1238: Targeting the platelet derived growth factor receptor (PDGFR) with the receptor tyrosine kinase inhibitor ponatinib in small cell carcinoma of the ovary, hypercalcemic type

Jessica Diane Lang, William Hendricks, Pilar Ramos, Holly Yin, Chris Sereduk, Jeffrey Kiefer, Yemin Wang, Anthony N. Karnezis, Bernard Weissman, David Huntsman, Jeffrey Trent

Cancer Res (2017) 77 (13_Supplement): 1238.

https://doi.org/10.1158/1538-7445.AM2017-1238

Published: 01 July 2017

View article titled, Abstract 1238: Targeting the platelet derived growth factor receptor (PDGFR) with the receptor tyrosine kinase inhibitor ponatinib in small cell carcinoma of the ovary, hypercalcemic type

Journal Articles

Abstract 5381: Therapeutic potential of HDAC inhibitors in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)

Yemin Wang, Pilar Ramos, Anthony N. Karnezis, Jeffrey M. Trent, David G. Huntsman

Cancer Res (2015) 75 (15_Supplement): 5381.

https://doi.org/10.1158/1538-7445.AM2015-5381

Published: 01 August 2015

View article titled, Abstract 5381: Therapeutic potential of HDAC inhibitors in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)

Journal Articles

Abstract 544: Recurrent DICER1 hotspot mutations in endometrial cancer and their impact on microRNA biogenesis

Jiamin Chen, Yemin Wang, Melissa McConechy, Michael Anglesio, Janine Senz, Winnie Yang, Jamie Rosner, Andy Chu, Grace Cheng, Gregg Morin, David Huntsman

Cancer Res (2014) 74 (19_Supplement): 544.

https://doi.org/10.1158/1538-7445.AM2014-544

Published: 01 October 2014

View article titled, Abstract 544: Recurrent DICER1 hotspot mutations in endometrial cancer and their impact on microRNA biogenesis

Journal Articles

p53 Is Positively Regulated by miR-542-3p

Yemin Wang, Jen-Wei Huang, Maria Castella, David George Huntsman, Toshiyasu Taniguchi

Cancer Res (2014) 74 (12): 3218–3227.

https://doi.org/10.1158/0008-5472.CAN-13-1706

Published: 12 June 2014

View article titled, p53 Is Positively Regulated by miR-542-3p

Includes: Supplementary data

Journal Articles

MiR-96 Downregulates REV1 and RAD51 to Promote Cellular Sensitivity to Cisplatin and PARP Inhibition

Yemin Wang, Jen-Wei Huang, Philamer Calses, Christopher J. Kemp, Toshiyasu Taniguchi

Cancer Res (2012) 72 (16): 4037–4046.

https://doi.org/10.1158/0008-5472.CAN-12-0103

Published: 14 August 2012

View article titled, MiR-96 Downregulates REV1 and RAD51 to Promote Cellular Sensitivity to Cisplatin and PARP Inhibition

Includes: Supplementary data

Journal Articles

Abstract 1947: Identification of microRNAs that regulate DNA damage response

Yemin Wang, Toshiyasu Taniguchi

Cancer Res (2010) 70 (8_Supplement): 1947.

https://doi.org/10.1158/1538-7445.AM10-1947

Published: 15 April 2010

View article titled, Abstract 1947: Identification of microRNAs that regulate DNA damage response

Journal Articles

Abstract #616: SCF^Skp2-mediated ING3 degradation regulates cell cycle control in melanoma cells

Guangdi Chen, Yemin Wang, Marco Garate, Jianwei Zhou, Gang Li

Cancer Res (2009) 69 (9_Supplement): 616.

Published: 01 May 2009

View article titled, Abstract #616: SCF<sup>Skp2</sup>-mediated ING3 degradation regulates cell cycle control in melanoma cells

Journal Articles

Role of SCF E3 ligase-mediated ING3 degradation in G1/S cell cycle transition

Yemin Wang, Marco Garate, Guangdi Chen, Ronald PC Wong, Gang Li

Cancer Res (2008) 68 (9_Supplement): 5072.

Published: 01 May 2008

View article titled, Role of SCF E3 ligase-mediated ING3 degradation in G1/S cell cycle transition

Journal Articles

Prognostic significance of ING3 subcellular localization in human cutaneous melanoma and its role in cell growth

Yemin Wang, Derek Dai, Magdalena Martinka, Gang Li

Cancer Res (2007) 67 (9_Supplement): 168.

Published: 01 May 2007

View article titled, Prognostic significance of ING3 subcellular localization in human cutaneous melanoma and its role in cell growth

NARROW

Bi-allelic Dicer1 mutations in the gynecologic tract of mice drive lineage-specific development of DICER1 syndrome-associated cancer

Abstract 23: Development of a biallelicDicer1mutant mouse strain for studying the pathogenesis of DICER1 syndrome-associated cancer

Abstract 3671: Targeting SLC2A1 and SLC38A2-mediated metabolic shift in SMARCA4/A2-dual deficient cancer

Abstract 1459: Selective killing of SMARCA4-deficient gynecologic cancers by mitochondria oxidative phosphorylation inhibitors

Abstract LB-038: Novel functional insights revealed by distinct protein-protein interactions of the residual SWI/SNF complex in SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type

Abstract 3673: Targeting the epigenome of small cell hypercalcemic carcinoma of the ovary, hypercalcemic type (SCCOHT)

Abstract 4318: Identifying drivers of SMARCA4/BRG1-deficient SCCOHT tumorigenesis by integrative multi-omic analysis

Abstract 1238: Targeting the platelet derived growth factor receptor (PDGFR) with the receptor tyrosine kinase inhibitor ponatinib in small cell carcinoma of the ovary, hypercalcemic type

Abstract 5381: Therapeutic potential of HDAC inhibitors in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)

Abstract 544: Recurrent DICER1 hotspot mutations in endometrial cancer and their impact on microRNA biogenesis

p53 Is Positively Regulated by miR-542-3p

MiR-96 Downregulates REV1 and RAD51 to Promote Cellular Sensitivity to Cisplatin and PARP Inhibition

Abstract 1947: Identification of microRNAs that regulate DNA damage response

Abstract #616: SCF^Skp2-mediated ING3 degradation regulates cell cycle control in melanoma cells

Role of SCF E3 ligase-mediated ING3 degradation in G1/S cell cycle transition

Prognostic significance of ING3 subcellular localization in human cutaneous melanoma and its role in cell growth

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only